With central banks weighing rate moves, energy prices swinging on Middle East tensions, and inflation signals mixed from the US to Asia, many investors are looking for focused ways to put cash to work without chasing hype. That is where the Elite Penny Stocks screener comes in, zeroing in on companies that still trade at low share prices but carry balance sheets built to support their growth plans. In this article, you will see three of the strongest stocks from the Elite Penny Stocks list and how each fits into today’s cross‑currents in rates, inflation and global demand.

Yatsen Holding (YSG)

Overview: Yatsen Holding is a Guangzhou based beauty company that develops and sells color cosmetics, skincare products, beauty tools and devices across China under brands such as Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU, Eve Lom and EANTiM, using a mix of online channels and physical stores.

Operations: Yatsen Holding currently generates around CN¥4.5b in revenue, all from the People’s Republic of China.

Market Cap: US$330.2m

Yatsen Holding operates within the skincare and beauty space in China’s online and offline retail networks. Analysts currently expect earnings growth while the company is still reporting losses and a negative return on equity. The recent Sephora rollout for Perfect Diary, rising skincare contributions and efforts to shift toward higher margin products are central to that thesis, while the low P/S ratio suggests the stock is priced cautiously relative to that outlook. However, heavy marketing spend, high share price volatility and reliance on external borrowing mean execution needs to remain disciplined or the path to sustained profitability could be challenging.

Yatsen Holding’s shift toward higher margin beauty lines and a low P/S ratio hints at a story the market may not fully be pricing in yet, so it is worth reviewing the 3 key rewards and 1 important warning sign

Grab Holdings (GRAB)

Overview: Grab Holdings runs a superapp across eight Southeast Asian countries that bundles ride-hailing, food and grocery delivery, payments, lending, insurance, digital banking and advertising into a single ecosystem for consumers, drivers and merchants. The app aims to be an all-in-one daily platform, from ordering meals and booking rides to paying bills and accessing basic financial services.

Operations: Grab Holdings currently generates about US$1.9b from Deliveries, US$1.3b from Mobility, US$379m from Financial Services and US$4m from other activities.

Market Cap: US$14.8b

Grab Holdings provides direct exposure to Southeast Asia’s shift toward app-based transport, food delivery and digital finance. Analysts report expectations of double digit revenue and earnings growth, as well as rising profit margins and earnings growth that have been very large in recent years. The company’s superapp model, strong cash position and expanding fintech and advertising businesses are often cited as central to its long term appeal. At the same time, investors may want to consider factors such as a relatively high P/E, significant use of non cash earnings and funding that relies on external borrowing rather than deposits. Recent insider share sales and mixed analyst sentiment add further complexity. Understanding how Grab’s growth profile, risks and current valuation relate to one another can be important context for anyone forming an investment view.

Grab Holdings is growing into a superapp across Southeast Asia. However, the full risk reward mix is easy to miss at a glance, so it is worth reading the 4 key rewards and 1 important major warning sign

Clover Health Investments (CLOV)

Overview: Clover Health Investments provides Medicare Advantage health insurance plans in the United States and uses its Clover Assistant software to help physicians identify and manage chronic conditions for Medicare eligible members.

Operations: Clover Health Investments generates about US$2.2b in revenue from its Insurance segment, all from the United States.

Market Cap: US$2.4b

Clover Health Investments combines a fast growing Medicare Advantage business with the Clover Assistant platform, which aims to lower medical costs and create opportunities for higher margin software revenue. The company operates in a part of healthcare where enrollment is expanding, while the stock trades on a low P/S multiple and is assessed as significantly below some estimates of fair value. At the same time, it remains unprofitable, carries funding risk from heavy use of external borrowing and faces regulatory and reimbursement uncertainty. Alongside recent cyber and insider selling headlines, this creates a complex story that may merit closer inspection rather than a quick glance at the share price chart.

Clover Health’s low P/S and tech enabled Medicare focus could be masking a sharper inflection point than the headline losses suggest, so it is worth reading the full narrative for Clover Health Investments

The three stocks in this article are just a starting sample. The full Elite Penny Stocks screener uncovered 18 more companies with similar cash runway strength and potential growth narratives that you have not seen yet. Unlock a broader view, identify the catalysts that matter to you, and analyze balance sheet resilience, earnings paths, and valuation signals in one place on Simply Wall St so you can focus on the highest conviction ideas.

Take Control of Your Investment Journey

If Clover Health Investments or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Beyond These Stocks?

Fresh ideas do not stay under the radar for long. Before the next breakout gains momentum and the best entry points get caught by the crowd, scan these curated picks and consider your options promptly.

• Spot resilient opportunities built on strong balance sheets and fundamentals, then run them through the list of solid balance sheet and fundamentals (48 results) to see which ones still look priced for potential upside.
• Explore long term income themes by searching for high yield payers in the 9 dividend fortresses while yields are still above the market average and sentiment has not fully adjusted.
• Review companies in the 34 robotics and automation stocks that may be positioned to benefit from increased automation spending while these stocks are still less widely followed.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.